A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progression
about
Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and preventionEmerging critical role of molecular testing in diagnostic genitourinary pathologyGenetic and Epigenetic Alterations in Bladder CancerHMCan: a method for detecting chromatin modifications in cancer samples using ChIP-seq data.Deregulation of Rab and Rab effector genes in bladder cancer.A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors.Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma.Pathobiology and chemoprevention of bladder cancerMetabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.Estrogen-induced chromatin decondensation and nuclear re-organization linked to regional epigenetic regulation in breast cancer.Bladder cancer: a simple model becomes complex.DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation statusHistone deacetylases: a saga of perturbed acetylation homeostasis in cancer.Segmental folding of chromosomes: a basis for structural and regulatory chromosomal neighborhoods?The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard.Hypermethylation in bladder cancer: biological pathways and translational applications.Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers.DNA methylation-based biomarkers in bladder cancer.Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.Molecular markers in bladder cancer: Novel research frontiers.SegCorr a statistical procedure for the detection of genomic regions of correlated expression.Tobacco-specific carcinogens induce hypermethylation, DNA adducts and DNA damage in Bladder Cancer.Oncogenic activity of amplified miniature chromosome maintenance 8 in human malignancies.The role of Kaposi's sarcoma-associated herpesvirus infection in the proliferation of human bladder cancer cells.PRC2-independent chromatin compaction and transcriptional repression in cancer.PI3K/AKT pathway activation in bladder carcinogenesis.Bladder cancer.Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer.DNA methylation in urothelial carcinoma.
P2860
Q26994739-FB28F322-5AE6-49D5-8109-74A4830974A4Q27021371-05522D60-5715-48D2-A8D1-D7472E5A8133Q28074732-4774D24B-9E8C-4972-BAAC-C41F2859A563Q30666001-BCA7E333-1EC3-4D2B-BD4A-E1F6BAD330AFQ34314461-5BB103E8-C89C-4570-A2A6-FF7445DFDFE1Q34524813-77E23C1C-F0E5-4BD8-86A4-9A36D10722CFQ34708383-2C073E18-3349-48A3-8863-B5924E0FD9D1Q35215704-AC55942B-3D2B-4532-AD6C-28C5744C5914Q35219328-05D46077-A1B6-41F4-B42E-5D5D743779A9Q35644340-D53708E0-FC97-44E7-96A5-8BF7FFC9DAE2Q35953777-C1D798C9-6C5C-403B-98BF-581C8D061A94Q36108115-D40D50D3-10F9-48F6-9FD3-230AA7AD77ABQ36187834-96F75B75-C73A-48CD-A788-EC7B54BEA0A4Q37416288-46DA8B5C-B4D9-4265-AE48-9AB92EE0750FQ37418601-6430F6C7-240C-45D6-A9D4-1A0C91084EB6Q37903407-2AE791C1-6739-412C-84DD-1D4D31F4F405Q37978544-44BE80BE-8075-4C93-B0F1-437B3C37A9BCQ38068225-3022B408-C4F8-4A16-BC12-D0C0CC6C88A6Q38102879-BD809547-25BB-467C-A315-061B2B080ABFQ38297729-F104BEC6-F16B-4C80-93DB-5D65F36D0D97Q38520403-FF54691D-0AB7-4CA8-B55F-CD2CD85377E3Q38683767-2B33F84F-6644-4A51-A570-E984C358BE4FQ38693874-4794C732-8F9D-4ACC-913C-166D2CE1D23EQ38704336-B241CAA4-B4AB-4EDD-BD8D-2DC66752B8EAQ38833714-3E6379FD-0DCE-426B-AED8-684D70C3D9D5Q39029997-B65344C2-287E-4969-B9E9-D49DDC394F85Q46976450-45F9BB26-750C-485D-859F-3BF93A3F84E4Q52810295-EB16B488-3F96-4B8D-9164-188A88F75DBAQ52839590-A971F610-D6F9-4C54-A9DA-711C41447F47Q53691833-64A18800-DEE1-4593-9E34-4C3DAF88EF69
P2860
A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progression
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A novel epigenetic phenotype a ...... y of bladder tumor progression
@ast
A novel epigenetic phenotype a ...... y of bladder tumor progression
@en
A novel epigenetic phenotype a ...... y of bladder tumor progression
@nl
type
label
A novel epigenetic phenotype a ...... y of bladder tumor progression
@ast
A novel epigenetic phenotype a ...... y of bladder tumor progression
@en
A novel epigenetic phenotype a ...... y of bladder tumor progression
@nl
prefLabel
A novel epigenetic phenotype a ...... y of bladder tumor progression
@ast
A novel epigenetic phenotype a ...... y of bladder tumor progression
@en
A novel epigenetic phenotype a ...... y of bladder tumor progression
@nl
P2093
P2860
P50
P356
P1476
A novel epigenetic phenotype a ...... y of bladder tumor progression
@en
P2093
Agnès Laplanche
Aurélie Hérault
Céline Vallot
Dimitri Vordos
Elodie Chapeaublanc
Isabelle Bernard-Pierrot
Nicolas Stransky
Thierry Lebret
Yves Allory
P2860
P356
10.1093/JNCI/DJQ470
P407
P577
2010-12-20T00:00:00Z